Literature DB >> 21436585

Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats.

Matthew J Alef1, Raghuveer Vallabhaneni, Evie Carchman, Sidney M Morris, Sruti Shiva, Yinna Wang, Eric E Kelley, Margaret M Tarpey, Mark T Gladwin, Edith Tzeng, Brian S Zuckerbraun.   

Abstract

Vascular disease, a significant cause of morbidity and mortality in the developed world, results from vascular injury. Following vascular injury, damaged or dysfunctional endothelial cells and activated SMCs engage in vasoproliferative remodeling and the formation of flow-limiting intimal hyperplasia (IH). We hypothesized that vascular injury results in decreased bioavailability of NO secondary to dysregulated arginine-dependent NO generation. Furthermore, we postulated that nitrite-dependent NO generation is augmented as an adaptive response to limit vascular injury/proliferation and can be harnessed for its protective effects. Here we report that sodium nitrite (intraperitoneal, inhaled, or oral) limited the development of IH in a rat model of vascular injury. Additionally, nitrite led to the generation of NO in vessels and SMCs, as well as limited SMC proliferation via p21Waf1/Cip1 signaling. These data demonstrate that IH is associated with increased arginase-1 levels, which leads to decreased NO production and bioavailability. Vascular injury also was associated with increased levels of xanthine oxidoreductase (XOR), a known nitrite reductase. Chronic inhibition of XOR and a diet deficient in nitrate/nitrite each exacerbated vascular injury. Moreover, established IH was reversed by dietary supplementation of nitrite. The vasoprotective effects of nitrite were counteracted by inhibition of XOR. These data illustrate the importance of nitrite-generated NO as an endogenous adaptive response and as a pathway that can be harnessed for therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21436585      PMCID: PMC3069768          DOI: 10.1172/JCI44079

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  62 in total

Review 1.  Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential.

Authors:  Fumito Ichinose; Jesse D Roberts; Warren M Zapol
Journal:  Circulation       Date:  2004-06-29       Impact factor: 29.690

Review 2.  The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics.

Authors:  Jon O Lundberg; Eddie Weitzberg; Mark T Gladwin
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

Review 3.  The L-arginine-nitric oxide pathway.

Authors:  S Moncada; A Higgs
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

Review 4.  The pathogenesis of atherosclerosis: a perspective for the 1990s.

Authors:  R Ross
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

5.  Diabetes-induced coronary vascular dysfunction involves increased arginase activity.

Authors:  Maritza J Romero; Daniel H Platt; Huda E Tawfik; Mohamed Labazi; Azza B El-Remessy; Manuela Bartoli; Ruth B Caldwell; Robert W Caldwell
Journal:  Circ Res       Date:  2007-10-25       Impact factor: 17.367

6.  Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator.

Authors:  Christian J Hunter; André Dejam; Arlin B Blood; Howard Shields; Daniel B Kim-Shapiro; Roberto F Machado; Selamawit Tarekegn; Neda Mulla; Andrew O Hopper; Alan N Schechter; Gordon G Power; Mark T Gladwin
Journal:  Nat Med       Date:  2004-09-12       Impact factor: 53.440

7.  Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells.

Authors:  S M Morris; D Kepka-Lenhart; L C Chen
Journal:  Am J Physiol       Date:  1998-11

Review 8.  Nitric oxide and arterial disease.

Authors:  Joel E Barbato; Edith Tzeng
Journal:  J Vasc Surg       Date:  2004-07       Impact factor: 4.268

Review 9.  Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

Authors:  Cristine E Berry; Joshua M Hare
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

10.  Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite.

Authors:  Andrew J Webb; Nakul Patel; Stavros Loukogeorgakis; Mike Okorie; Zainab Aboud; Shivani Misra; Rahim Rashid; Philip Miall; John Deanfield; Nigel Benjamin; Raymond MacAllister; Adrian J Hobbs; Amrita Ahluwalia
Journal:  Hypertension       Date:  2008-02-04       Impact factor: 10.190

View more
  48 in total

1.  Nitrite-NO bailout for a NOS complex too big to fail.

Authors:  Mark T Gladwin; Jesús Tejero
Journal:  Nat Med       Date:  2011-12-06       Impact factor: 53.440

2.  Nitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation.

Authors:  Matthias Totzeck; Ulrike B Hendgen-Cotta; Peter Luedike; Michael Berenbrink; Johann P Klare; Heinz-Juergen Steinhoff; Dominik Semmler; Sruti Shiva; Daryl Williams; Anja Kipar; Mark T Gladwin; Juergen Schrader; Malte Kelm; Andrew R Cossins; Tienush Rassaf
Journal:  Circulation       Date:  2012-06-09       Impact factor: 29.690

3.  Xanthine Oxidoreductase Function Contributes to Normal Wound Healing.

Authors:  Michael C Madigan; Ryan M McEnaney; Ankur J Shukla; Guiying Hong; Eric E Kelley; Margaret M Tarpey; Mark Gladwin; Brian S Zuckerbraun; Edith Tzeng
Journal:  Mol Med       Date:  2015-04-14       Impact factor: 6.354

4.  Large elastic artery stiffness with aging: novel translational mechanisms and interventions.

Authors:  Bradley S Fleenor
Journal:  Aging Dis       Date:  2012-12-11       Impact factor: 6.745

Review 5.  Inorganic nitrite supplementation for healthy arterial aging.

Authors:  Amy L Sindler; Allison E Devan; Bradley S Fleenor; Douglas R Seals
Journal:  J Appl Physiol (1985)       Date:  2014-01-09

Review 6.  Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health.

Authors:  Carl D Koch; Mark T Gladwin; Bruce A Freeman; Jon O Lundberg; Eddie Weitzberg; Alison Morris
Journal:  Free Radic Biol Med       Date:  2016-12-16       Impact factor: 7.376

Review 7.  Is nitric oxide a hormone?

Authors:  Asghar Ghasemi; Saleh Zahediasl
Journal:  Iran Biomed J       Date:  2011

8.  Nitrite reductase and nitric-oxide synthase activity of the mitochondrial molybdopterin enzymes mARC1 and mARC2.

Authors:  Courtney E Sparacino-Watkins; Jesús Tejero; Bin Sun; Marc C Gauthier; John Thomas; Venkata Ragireddy; Bonnie A Merchant; Jun Wang; Ivan Azarov; Partha Basu; Mark T Gladwin
Journal:  J Biol Chem       Date:  2014-02-05       Impact factor: 5.157

9.  Sulfite Oxidase Catalyzes Single-Electron Transfer at Molybdenum Domain to Reduce Nitrite to Nitric Oxide.

Authors:  Jun Wang; Sabina Krizowski; Katrin Fischer-Schrader; Dimitri Niks; Jesús Tejero; Courtney Sparacino-Watkins; Ling Wang; Venkata Ragireddy; Sheila Frizzell; Eric E Kelley; Yingze Zhang; Partha Basu; Russ Hille; Guenter Schwarz; Mark T Gladwin
Journal:  Antioxid Redox Signal       Date:  2014-12-11       Impact factor: 8.401

Review 10.  Xanthine oxidoreductase-catalyzed reduction of nitrite to nitric oxide: insights regarding where, when and how.

Authors:  Nadiezhda Cantu-Medellin; Eric E Kelley
Journal:  Nitric Oxide       Date:  2013-02-27       Impact factor: 4.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.